Stay updated on PD-1 Blockade in AML Clinical Trial
Sign up to get notified when there's something new on the PD-1 Blockade in AML Clinical Trial page.

Latest updates to the PD-1 Blockade in AML Clinical Trial page
- Check7 days agoChange DetectedNew history entries were added for 2026-03-18 through 2026-03-25 (versions 101–105). The updates include changes to the Study Status in the record history.SummaryDifference0.6%

- Check14 days agoChange DetectedDifference0.5%

- Check21 days agoChange DetectedA new revision (v3.4.3) was added along with updated Study Status entries through 2026-03-11, indicating recent changes to the record history.SummaryDifference0.8%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision history shows a new entry: v3.4.2 added, and the earlier notices about funding lapse and operating status (v3.4.1) were removed; these updates do not affect the core study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page now displays a lapse-in-funding notice and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedThe Record History page adds a Show glossary option and color-coded highlights for additions and deletions, and updates revision labeling to v3.4.0, while the No FEAR Act Data text is removed.SummaryDifference0.4%

Stay in the know with updates to PD-1 Blockade in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Blockade in AML Clinical Trial page.